GenRx Pemetrexed pemetrexed 500 mg (as disodium) powder for injection vial

Țară: Australia

Limbă: engleză

Sursă: Department of Health (Therapeutic Goods Administration)

Ingredient activ:

pemetrexed disodium hemipentahydrate, Quantity: 604 mg (Equivalent: pemetrexed, Qty 500 mg)

Disponibil de la:

Arrotex Pharmaceuticals Pty Ltd

INN (nume internaţional):

pemetrexed disodium hemipentahydrate

Forma farmaceutică:

Injection, powder for

Compoziție:

Excipient Ingredients: mannitol; hydrochloric acid; sodium hydroxide

Calea de administrare:

Intravenous Infusion

Unități în pachet:

1

Tip de prescriptie medicala:

(S4) Prescription Only Medicine

Indicații terapeutice:

Malignant Pleural Mesothelioma,Pemetrexed, in combination with cisplatin, is indicated for the treatment of patients with malignant pleural mesothelioma.,Non-Small Cell Lung Cancer (NSCLC),Pemetrexed, in combination with cisplatin, is indicated for initial treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology.,Pemetrexed, as monotherapy, is indicated for the treatment of patients with locally advanced or metastatic NSCLC other than predominantly squamous cell histology after prior platinum-based chemotherapy.

Rezumat produs:

Visual Identification: White to either light yellow or green-yellow powder.; Container Type: Vial; Container Material: Glass; Container Life Time: 24 Months; Container Temperature: Store below 25 degrees Celsius; Container Closure: Neither child resistant closure nor restricted flow insert

Statutul autorizaţiei:

Licence status A

Data de autorizare:

2014-09-04